Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma

Table 3

TBUT and OSDI at baseline and 3 months after starting treatment with BAK-preserved travoprost 0.004% in newly diagnosed POAG patients (𝑛=40) included in the study.

Parameter	Baseline	After 3 months	𝑃
TBUT (sec)*	11.70±1.86	8.30±1.29	<0.001
OSDI*	31.63±18.48	44.41±16.48	<0.001

∗Mean ± SD.
IOP: intraocular pressure; TBUT: tear break-up time; OSDI: ocular surface disease index.